Faron Pharmaceuticals - Innovative medical solutions (Part 2)

[Clark_kent]

@samunho

So now we have seen that despite the transplant-ineligible status, many patients have reached a state where they are in remission and blood counts are OK. Therefore, even though the patients were not originally transplant-eligible, they have successfully proceeded to transplant; the treatment has thus made the possibility of a transplant available.

That criterion is in the upcoming Bexera trial, not in Bexmab, the results of which we have now…